Increased resting energy expenditure in cystic fibrosis

1988 ◽  
Vol 64 (5) ◽  
pp. 1810-1816 ◽  
Author(s):  
R. M. Buchdahl ◽  
M. Cox ◽  
C. Fulleylove ◽  
J. L. Marchant ◽  
A. M. Tomkins ◽  
...  

To explore the hypothesis that there is an increased metabolic rate in cystic fibrosis, resting energy expenditure was measured by indirect calorimetry in 23 subjects with cystic fibrosis in a stable clinical state and in 42 normal control subjects. Resting energy expenditure was found to be elevated by an average of 0.45 MJ/24 h [95% confidence interval (CI) = 0.26–0.64, t = 4.91, P less than 0.001] (108 kcal/24 h), or 9.2% above expected values derived from the regression relating resting energy expenditure to whole body weight and sex in control subjects. When related to lean body mass, values were still elevated by 0.36 MJ/24 h (95% CI = 0.18–0.53, t = 4.15, P less than 0.001) (86 kcal/24 h), or 7.2%. The increased values were found to be independent of age, sex, or body size. There were significant correlations between increased values and poor pulmonary function as measured by the ratio of the forced expiratory volume in 1 s to forced vital capacity (r = -0.44, P less than 0.05) and subclinical infection as indicated by the blood leukocyte count (r = 0.40, P less than 0.05). However, the correlations were low, suggesting that other factors may contribute to the increased resting energy expenditure, possibly including the putative metabolic defect in cystic fibrosis.

1993 ◽  
Vol 85 (5) ◽  
pp. 563-568 ◽  
Author(s):  
J. Stuart Elborn ◽  
Sally M. Cordon ◽  
Philip J. Western ◽  
Ian A. MaCdonald ◽  
Dennis J. Shale

1. We investigated the relationship between circulating tumour necrosis factor-α concentrations, resting energy expenditure, cachexia and altered intermediary metabolism in patients with cystic fibrosis and chronic pulmonary infection. 2. Twenty adult patients with cystic fibrosis and chronic bronchial sepsis covering a spectrum of severity of lung disease (forced expiratory volume in 1 s 30–100% of predicted) were compared with 10 age matched, healthy, non-cystic fibrosis subjects. 3. Circulating tumour necrosis factor-α, C-reactive protein and neutrophil elastase-α1-antiproteinase complex concentrations were determined simultaneously with glycerol, non-esterified fatty acids, catecholamines, anthropometric indices and resting energy expenditure (ventilated hood method). 4. Weight, body mass index and arm muscle mass were reduced in patients with cystic fibrosis compared with healthy control subjects (P <0.01), whereas mean resting energy expenditure was increased [121 versus 101% predicted, mean difference 19.2% (95% confidence interval 11.0-27.4%), P <0.001]. Circulating concentrations of glycerol (P <0.01), non-esterified fatty acids (P <0.01), adrenaline (P <0.05), tumour necrosis factor-α, C-reactive protein and neutrophil elastase-α1-antiproteinase complex (P <0.01) were increased in patients compared with control subjects [tumour necrosis factor-α 96.9 versus 24.7 pg/ml, mean difference 72.2 pg/ml [95% confidence interval 27.7-116.7 pg/ml), P <0.001]. Resting energy expenditure was significantly related to tumour necrosis factor-α levels and forced expiratory volume in 1 s. 5. In patients with cystic fibrosis and chronic pulmonary sepsis changes in resting energy expenditure, body composition and intermediary metabolism are consistent with the systemic effects of the host inflammatory response, which may be responsible for cachexia in adult patients. In particular these changes are consistent with the action of tumour necrosis factor-α, which was detected in the circulation during a period of apparent clinical stability.


2008 ◽  
Vol 152 (5) ◽  
pp. 703-708 ◽  
Author(s):  
Annabel Magoffin ◽  
Jane R. Allen ◽  
James McCauley ◽  
Margie A. Gruca ◽  
Jenny Peat ◽  
...  

1991 ◽  
Vol 119 (6) ◽  
pp. 913-916 ◽  
Author(s):  
Martin D. Fried ◽  
Peter R. Durie ◽  
Lap-Chee Tsui ◽  
Mary Corey ◽  
Henry Levison ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document